Common use of Clear and Reasonable Warnings Clause in Contracts

Clear and Reasonable Warnings. For any Covered Products manufactured after the Effective Date that do not qualify as Reformulated Covered Products and are directly sold or offered for sale in California by Apothekary after the Effective Date, Apothekary shall only sell or offer said non-reformulated Covered Products for sale in California when accompanied with one of the following warnings: WARNING: Consuming this product can expose you to lead which is known to the State of California to cause birth defects and other reproductive harm. For more information go to: xxx.X00xxxxxxxx.XX.xxx/xxxx” OR: WARNING: Reproductive Harm – xxx.X00Xxxxxxxx.xx.xxx/xxxx” The warning provided pursuant to Section 2.3 shall be prominently affixed to or printed on the Covered Product’s packaging or label with such conspicuousness, as compared with other words, statements, or designs as to render it likely to be read and understood by an ordinary individual under customary conditions of purchase or use. If the warning is provided on the label, it must be set off from other surrounding information and enclosed in a box. In the event Apothekary provides the warning pursuant to OPTION 2, above, the entire warning must be in a type size no smaller than the largest size used for other consumer information on the product, and in no case shall the warning appear in a type size smaller than 6-point type. Further, for Option 2 Warning, a symbol consisting of a black exclamation point in a yellow equilateral triangle with a bold black outline must be placed to the left of the text of the warning in a size no smaller than the height of the word “WARNING”. If the sign, label, or shelf tag for the product is not printed using the color yellow, the symbol may be provided in black and white. For all warnings, the word “WARNING” shall be in all capital letters in bold print. Any additional statements in the warning shall comply with Title 27, California Code of Regulations, Section 25601(e). In the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirements. In addition, for any Covered Product sold over the internet where a California delivery address is indicated, the warning shall be provided either by including the warning on the product display page, by otherwise prominently displaying the warning to the purchaser during the checkout process prior to completing the purchase, or by any other means authorized under Section 25607.1 of Title 27 of the California Code of Regulations. An asterisk or other identifying method must be utilized to identify which products on the checkout page are subject to the warning. The Warning may be provided with a conspicuous hyperlink stating “WARNING” in all capital and bold letters so long as the hyperlink goes to a page directly to a page prominently displaying the Warning without content that detracts from the Warning. Given Apothekary’s lack of control over third-party websites, the online warning requirements expressed in this section only apply to the Covered Products when sold through Apothekary’s website. With respect to any downstream reseller customers of Apothekary who are subject to Proposition 65, Apothekary may give written notice, including labels, labeling, shelf signs, or tags bearing the Warning and all necessary warning materials to the authorized agent of such downstream reseller customers. Such written notice shall instruct the downstream reseller customers that the labels, labeling, shelf signs, or tags bearing the Warning must be displayed in such conspicuousness, as compared with other words, statements, or designs, as to render the Warning likely to be seen, read, and understood by an ordinary individual prior to sale. In the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirements.

Clear and Reasonable Warnings. For any Covered Products manufactured after the Effective Date that do not qualify as Reformulated Covered Products and are directly sold or offered for sale in California by Apothekary Sakara Life after the Effective Date, Apothekary Sakara Life shall only sell or offer said non-reformulated Covered Products for sale in California when accompanied with one of the following warnings: warnings (or such other warnings as are permitted or required by applicable California law from time to time): WARNING: Consuming this product can expose you to lead [chemicals including] [lead] which is [are] known to the State of California to cause [cancer and] birth defects and or other reproductive harm. For more information go to: xxx.X00xxxxxxxx.XX.xxx/xxxx” to xxx.X00Xxxxxxxx.xx.xxx/xxxx. OR: WARNING: [Cancer and] Reproductive Harm – xxx.X00Xxxxxxxx.xx.xxx/xxxx” The Sakara Life shall use the phrase “cancer and” in the warning if Sakara Life has reason to believe that the “Daily Lead Exposure Level” is greater than 15 micrograms of lead, or if Sakara Life has reason to believe that another Proposition 65 chemical is present which may require a cancer warning. Subject to applicable California law from time to time, a. the warning provided pursuant to Section 2.3 shall be prominently affixed to or printed on the Covered Product’s packaging or label with such conspicuousness, as compared with other words, statements, or designs as to render it likely to be read and understood by an ordinary individual under customary conditions of purchase or use. . b. If the warning is provided on the label, it must be set off from other surrounding information and enclosed in a box. In the event Apothekary provides the warning pursuant to OPTION 2, above, the entire warning must be in a type size no smaller than the largest size used for other consumer information on the product, and in no case shall the warning appear in a type size smaller than 6-point type. Further, for Option 2 Warning, a symbol consisting of a black exclamation point in a yellow equilateral triangle with a bold black outline must be placed to the left of the text of the warning in a size no smaller than the height of the word “WARNING”. If the sign, label, or shelf tag for the product is not printed using the color yellow, the symbol may be provided in black and white. For all warnings, the word “WARNING” shall be in all capital letters in bold print. Any additional statements in the warning shall comply with Title 27, California Code of Regulations, Section 25601(e). In the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirements. . c. In addition, for any Covered Product sold over the internet where a California delivery address is indicated, the warning shall be provided either by including the warning on the product display page, by otherwise prominently displaying the warning to the purchaser during the checkout process prior to completing the purchase, or by any other means authorized under Section 25607.1 of Title 27 of the California Code of Regulations. An asterisk or other identifying method . d. In the event Sakara Life provides the warning pursuant to OPTION 2, above, the entire warning must be utilized to identify which products in a type size no smaller than the largest size used for other consumer information on the checkout page are subject to product, and in no case shall the warningwarning appear in a type size smaller than 6-point type. The Warning may be provided with a conspicuous hyperlink stating For all warnings, the word “WARNING” shall be in all capital letters in bold print. Any additional statements in the warning shall comply with Title 27, California Code of Regulations, Section 25601(e). Notwithstanding the foregoing and bold letters so long as the hyperlink goes to a page directly to a page prominently displaying the Warning without content that detracts from the Warning. Given Apothekary’s lack of control over third-party websitesfor absolute clarity, the online warning requirements expressed in this section only apply Parties acknowledge and agree that if Sakara Life has met the obligations under Title 27 of the California Code of Regulations (as amended from time to the Covered Products when sold through Apothekary’s website. With respect time), it shall be deemed to any downstream reseller customers of Apothekary who are subject to Proposition 65, Apothekary may give written notice, including labels, labeling, shelf signs, or tags bearing the Warning and all necessary warning materials to the authorized agent of such downstream reseller customers. Such written notice shall instruct the downstream reseller customers that the labels, labeling, shelf signs, or tags bearing the Warning must be displayed in such conspicuousness, as compared with other words, statements, or designs, as to render the Warning likely to be seen, read, and understood by an ordinary individual prior to sale. In the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of have satisfied its warning label so long as it remains consistent with legal and regulatory requirementsobligations hereunder.

Clear and Reasonable Warnings. For any Covered Products manufactured after the Effective Date that do not qualify as Reformulated Covered Products and are directly sold or offered for sale in California by Apothekary after the Effective DateIf Bulletproof is required to provide a warning pursuant to Section 2.1, Apothekary shall only sell or offer said non-reformulated Covered Products for sale in California when accompanied with one of the following warningswarnings must be utilized ("Warning"). Option 1: WARNING: Consuming this product can expose you to lead chemicals including lead, which is known to the State of California to cause [cancer and], birth defects and or other reproductive harm. For more information go to: xxx.X00xxxxxxxx.XX.xxx/xxxx” OR: to xxx.X00Xxxxxxxx.xx.xxx/xxxx WARNING: [Cancer and] Reproductive Harm – xxx.X00Xxxxxxxx.xx.xxx/xxxx” xxx.X00Xxxxxxxx.xx.xxx/xxxx Bulletproof shall use the phrase "cancer and" in the Warning if the exposure level is greater than 15 micrograms of lead per day. The warning provided pursuant to Section 2.3 Warning shall be prominently securely affixed to or printed on upon the label of each Covered Product’s packaging or label with such conspicuousness, as compared with other words, statements, or designs as to render it likely to be read Product and understood by an ordinary individual under customary conditions of purchase or use. If the warning is provided on the label, it must be set off from other surrounding information and information. For purposes of this Settlement Agreement, the term "label" means a display of written, printed or graphic material that is printed on or affixed to a Covered Product or its immediate container or wrapper. The warning must be set off from other surrounding information, enclosed in a box. In the event Apothekary provides the warning pursuant to OPTION 2, above, the entire warning must be in a type size no smaller than the largest size used for other If consumer information on the productpackage is in a foreign language, and in no case shall the warning appear in a type size smaller than 6-point type. Further, for Option 2 Warning, a symbol consisting of a black exclamation point in a yellow equilateral triangle with a bold black outline must be placed to the left of the text of the warning in a size no smaller than the height of the word “WARNING”. If the sign, label, or shelf tag for the product is not printed using the color yellow, the symbol may also be provided in black and white. For all warnings, the word “WARNING” shall be in all capital letters in bold print. Any additional statements in the warning shall comply with Title 27, California Code of Regulations, Section 25601(e). In the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirementsforeign language. In addition, for any Covered Product sold over the internet where internet, the Warning shall appear on the product display page or the checkout page in full text, or through a clearly marked hyperlink using the word "WARNING" in all capital and bold letters. The warning is only required when a California delivery address is indicatedindicated for any purchase of any Covered Product. If a hyperlink is used, the warning shall be provided either by including the warning on the product display page, by otherwise hyperlink must go directly to a page prominently displaying either the warning to Option 1 Warning or the purchaser during Option 2 Warning without content that detracts from the checkout process prior to completing the purchase, or by any other means authorized under Section 25607.1 of Title 27 of the California Code of RegulationsWarning. An asterisk or other identifying method must be utilized to identify which products on the checkout page are subject to the warningWarning. The Warning Alternatively, the content and method of transmission may be provided with a conspicuous hyperlink stating “WARNING” in all capital and bold letters so long any form as the hyperlink goes to a page directly to a page prominently displaying the Warning without content that detracts from the Warning. Given Apothekary’s lack of control over third-party websites, the online warning requirements expressed in this section only apply to the Covered Products when sold through Apothekary’s website. With respect to any downstream reseller customers of Apothekary who are subject to Proposition 65, Apothekary may give written notice, including labels, labeling, shelf signs, or tags bearing the Warning and all necessary warning materials to the authorized agent of such downstream reseller customers. Such written notice shall instruct the downstream reseller customers that the labels, labeling, shelf signs, or tags bearing the Warning must be displayed in such conspicuousness, as compared with other words, statements, or designs, as to render the Warning likely to be seen, read, and understood by an ordinary individual prior to sale. In the event that warnings requirements under Proposition 65 are modified law or regulation effective on or after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirements.

Clear and Reasonable Warnings. For any Covered Products manufactured after the Effective Date that do not qualify as Reformulated Covered Products and are directly sold or offered for sale in California by Apothekary after the Effective DateIf Asha is required to provide a warning pursuant to Section 2.1, Apothekary shall only sell or offer said non-reformulated Covered Products for sale in California when accompanied with one of the following warningswarnings must be utilized ("Warning"): Option 1: WARNING: Consuming this product can expose you to lead chemicals including lead, which is known to the State of California to cause [cancer and], birth defects and or other reproductive harm. For more information go to: xxx.X00xxxxxxxx.XX.xxx/xxxx” OR: to xxx.X00Xxxxxxxx.xx.xxx/xxxx WARNING: [Cancer and] Reproductive Harm – xxx.X00Xxxxxxxx.xx.xxx/xxxx” xxx.X00Xxxxxxxx.xx.xxx/xxxx Xxxx shall use the phrase "cancer and" in the Warning if Xxxx has reason to believe that the "Daily Lead Exposure Level" is greater than 15 micrograms of lead or if Xxxx has reason to believe that another Proposition 65 chemical is present which may require a cancer warning. The warning provided pursuant to Section 2.3 Warning shall be prominently securely affixed to or printed on upon the label of each Covered Product’s packaging or label with such conspicuousness, as compared with other words, statements, or designs as to render it likely to be read Product and understood by an ordinary individual under customary conditions of purchase or use. If the warning is provided on the label, it must be set off from other surrounding information and enclosed in a boxinformation. In addition, for any Covered Product sold over the event Apothekary provides the warning pursuant to OPTION 2, aboveinternet, the entire warning Warning shall appear on the checkout page in full text or through a clearly marked hyperlink using the word "WARNING" in all capital and bold letters when a California delivery address is indicated for any purchase of any Covered Product. If a hyperlink is used, the hyperlink must go directly to a page prominently displaying either the Option 1 Warning or the Option 2 Warning without content that detracts from the Warning. An asterisk or other identifying method must be in a type utilized to identify which products on the checkout page are subject to the Warning. The Warning shall be at least the same size no smaller than as the largest size used for of any other consumer information health or safety warnings also appearing on the product, website or on the label and the word "WARNING" shall be in all capital letters and in no case bold print. No statements intended to or likely to have the effect of diminishing the impact of the Warning on the average lay person shall accompany the warning appear in a type size smaller than 6-point typeWarning. Further, for no statements may accompany the Warning that state or imply that the source of the listed chemical has an impact on or results in a less harmful effect of the listed chemical. For the Option 2 Warning, a symbol consisting of a black exclamation point in a yellow equilateral triangle with a bold black outline must shall be placed to the left of the text of the warning Warning, in a size no smaller than the height of the word “''WARNING”. If ." Asha must display the sign, label, or shelf tag for the product is not printed using the color yellow, the symbol may be provided in black and white. For all warnings, the word “WARNING” shall be in all capital letters in bold print. Any additional statements in the warning shall comply above Warning with Title 27, California Code of Regulations, Section 25601(e). In the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirements. In addition, for any Covered Product sold over the internet where a California delivery address is indicated, the warning shall be provided either by including the warning on the product display page, by otherwise prominently displaying the warning to the purchaser during the checkout process prior to completing the purchase, or by any other means authorized under Section 25607.1 of Title 27 of the California Code of Regulations. An asterisk or other identifying method must be utilized to identify which products on the checkout page are subject to the warning. The Warning may be provided with a conspicuous hyperlink stating “WARNING” in all capital and bold letters so long as the hyperlink goes to a page directly to a page prominently displaying the Warning without content that detracts from the Warning. Given Apothekary’s lack of control over third-party websites, the online warning requirements expressed in this section only apply to the Covered Products when sold through Apothekary’s website. With respect to any downstream reseller customers of Apothekary who are subject to Proposition 65, Apothekary may give written notice, including labels, labeling, shelf signs, or tags bearing the Warning and all necessary warning materials to the authorized agent of such downstream reseller customers. Such written notice shall instruct the downstream reseller customers that the labels, labeling, shelf signs, or tags bearing the Warning must be displayed in such conspicuousness, as compared with other words, statementsstatements or designs on the label, or designson its website, as if applicable, to render the Warning likely to be seen, read, read and understood by an ordinary individual prior under customary conditions of purchase or use of the product. For purposes of this Settlement Agreement, the term "label" means a display of written, printed or graphic material that is printed on or affixed to salea Covered Product or its immediate container or wrapper. In Compliance with Proposition 65, as amended from time to time, shall be deemed compliance with this section 2 of the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirementsSettlement Agreement.

Clear and Reasonable Warnings. For any Covered Products manufactured after the Effective Date that do not qualify as Reformulated Covered Products and are directly sold or offered for sale in California by Apothekary after the Effective DateIf VitaHustle is required to provide a warning pursuant to Section 2.1, Apothekary shall only sell or offer said non-reformulated Covered Products for sale in California when accompanied with one of the following warningswarnings must be utilized ("Warning"): Option 1: WARNING: Consuming this product can expose you to lead lead, which is known to the State of California to cause [cancer and] birth defects and or other reproductive harm. For more information go to: xxx.X00xxxxxxxx.XX.xxx/xxxx” OR: to xxx.X00Xxxxxxxx.xx.xxx/xxxx WARNING: [Cancer and] Reproductive Harm – xxx.X00Xxxxxxxx.xx.xxx/xxxxxxx.X00Xxxxxxxx.xx.xxx/xxxx VitaHustle shall use the phrase “cancer and” in the Warning if the “Daily Lead Exposure Level” is greater than 15 micrograms of Lead. The warning provided pursuant to Section 2.3 shall Warningshall be prominently securely affixed to or printed on upon the label of each Covered Product’s packaging Product or label with such conspicuousness, as compared with other words, statements, or designs as to render it likely to be read at the point of sale and understood by an ordinary individual under customary conditions of purchase or use. If the warning is provided on the label, it must be set off from other surrounding information and enclosed in a boxinformation. In addition, for any Covered Product sold over the event Apothekary provides the warning pursuant to OPTION 2, aboveinternet, the entire warning must be in a type size no smaller than the largest size used for other consumer information Warning shall appear on the productproduct page or checkout page in full text or through a clearly marked hyperlink using the word "WARNING" in all capital and bold letters when a California delivery address is indicated for any purchase of any Covered Product. If a hyperlink is used, and in no case the hyperlink must go directly to a page prominently displaying either the Option 1 Warning or the Option 2 Warning without content that detracts from the Warning. No statements intended to or likely to have the effect of diminishing the impact of the Warning on the average lay person shall accompany the warning appear in a type size smaller than 6-point typeWarning. Further, for For the Option 2 Warning, a symbol consisting of a black exclamation point in a yellow equilateral triangle with a bold black outline must shall be placed to the left of the text of the warning Warning, in a size no smaller than the height of the word “''WARNING”. ." If consumer information on the sign, label, or shelf tag for the product package is not printed using the color yellowin a foreign language, the symbol may warning must also be provided in black and whitethe foreign language. For all warnings, VitaHustle must display the word “WARNING” shall be in all capital letters in bold print. Any additional statements in the warning shall comply above Warning with Title 27, California Code of Regulations, Section 25601(e). In the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirements. In addition, for any Covered Product sold over the internet where a California delivery address is indicated, the warning shall be provided either by including the warning on the product display page, by otherwise prominently displaying the warning to the purchaser during the checkout process prior to completing the purchase, or by any other means authorized under Section 25607.1 of Title 27 of the California Code of Regulations. An asterisk or other identifying method must be utilized to identify which products on the checkout page are subject to the warning. The Warning may be provided with a conspicuous hyperlink stating “WARNING” in all capital and bold letters so long as the hyperlink goes to a page directly to a page prominently displaying the Warning without content that detracts from the Warning. Given Apothekary’s lack of control over third-party websites, the online warning requirements expressed in this section only apply to the Covered Products when sold through Apothekary’s website. With respect to any downstream reseller customers of Apothekary who are subject to Proposition 65, Apothekary may give written notice, including labels, labeling, shelf signs, or tags bearing the Warning and all necessary warning materials to the authorized agent of such downstream reseller customers. Such written notice shall instruct the downstream reseller customers that the labels, labeling, shelf signs, or tags bearing the Warning must be displayed in such conspicuousness, as compared with other words, statementsstatements or designs on the label, or designson its website, as if applicable, to render the Warning likely to be seen, read, read and understood by an ordinary individual prior to saleunder customary conditions of purchase or use of the product. In Notwithstanding the event that warnings requirements under above, the content and method of transmission shall be provided in any form as authorized by Proposition 65 are modified law or regulation, applicable to the Covered Product and chemical at issue, effective on or after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirements.

Clear and Reasonable Warnings. For any Covered Products manufactured after the Effective Date that do not qualify as Reformulated Covered Products and are directly sold or offered for sale in California by Apothekary Sakara Life after the Effective Date, Apothekary Sakara Life shall only sell or offer said non-reformulated Covered Products for sale in California when accompanied with one of the following warnings: warnings (or such other warnings as are permitted or required by applicable California law from time to time): WARNING: Consuming this product can expose you to lead [chemicals including] [lead] [and] [cadmium] which is [are] known to the State of California to cause [cancer and] birth defects and or other reproductive harm. For more information go to: xxx.X00xxxxxxxx.XX.xxx/xxxx” to xxx.X00Xxxxxxxx.xx.xxx/xxxx. OR: WARNING: [Cancer and] Reproductive Harm – xxx.X00Xxxxxxxx.xx.xxx/xxxx” The Sakara Life shall use the phrase “cancer and” in the warning if Sakara Life has reason to believe that the “Daily Lead Exposure Level” is greater than 15 micrograms of lead, or if Sakara Life has reason to believe that another Proposition 65 chemical is present which may require a cancer warning. Subject to applicable California law from time to time, a. the warning provided pursuant to Section 2.3 shall be prominently affixed to or printed on the Covered Product’s packaging or label with such conspicuousness, as compared with other words, statements, or designs as to render it likely to be read and understood by an ordinary individual under customary conditions of purchase or use. . b. If the warning is provided on the label, it must be set off from other surrounding information and enclosed in a box. In the event Apothekary provides the warning pursuant to OPTION 2, above, the entire warning must be in a type size no smaller than the largest size used for other consumer information on the product, and in no case shall the warning appear in a type size smaller than 6-point type. Further, for Option 2 Warning, a symbol consisting of a black exclamation point in a yellow equilateral triangle with a bold black outline must be placed to the left of the text of the warning in a size no smaller than the height of the word “WARNING”. If the sign, label, or shelf tag for the product is not printed using the color yellow, the symbol may be provided in black and white. For all warnings, the word “WARNING” shall be in all capital letters in bold print. Any additional statements in the warning shall comply with Title 27, California Code of Regulations, Section 25601(e). In the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of its warning label so long as it remains consistent with legal and regulatory requirements. . c. In addition, for any Covered Product sold over the internet where a California delivery address is indicated, the warning shall be provided either by including the warning on the product display page, by otherwise prominently displaying the warning to the purchaser during the checkout process prior to completing the purchase, or by any other means authorized under Section 25607.1 of Title 27 of the California Code of Regulations. An asterisk or other identifying method . d. In the event Sakara Life provides the warning pursuant to OPTION 2, above, the entire warning must be utilized to identify which products in a type size no smaller than the largest size used for other consumer information on the checkout page are subject to product, and in no case shall the warningwarning appear in a type size smaller than 6-point type. The Warning may be provided with a conspicuous hyperlink stating For all warnings, the word “WARNING” shall be in all capital letters in bold print. Any additional statements in the warning shall comply with Title 27, California Code of Regulations, Section 25601(e). Notwithstanding the foregoing and bold letters so long as the hyperlink goes to a page directly to a page prominently displaying the Warning without content that detracts from the Warning. Given Apothekary’s lack of control over third-party websitesfor absolute clarity, the online warning requirements expressed in this section only apply Parties acknowledge and agree that if Sakara Life has met the obligations under Title 27 of the California Code of Regulations (as amended from time to the Covered Products when sold through Apothekary’s website. With respect time), it shall be deemed to any downstream reseller customers of Apothekary who are subject to Proposition 65, Apothekary may give written notice, including labels, labeling, shelf signs, or tags bearing the Warning and all necessary warning materials to the authorized agent of such downstream reseller customers. Such written notice shall instruct the downstream reseller customers that the labels, labeling, shelf signs, or tags bearing the Warning must be displayed in such conspicuousness, as compared with other words, statements, or designs, as to render the Warning likely to be seen, read, and understood by an ordinary individual prior to sale. In the event that warnings requirements under Proposition 65 are modified after the Effective Date, Apothekary reserves the right to amend the form and content of have satisfied its warning label so long as it remains consistent with legal and regulatory requirementsobligations hereunder.